Antinuclear antibodies:: to penetrate or not to penetrate, that was the question

被引:22
作者
Alarcón-Segovia, D
机构
[1] Inst Nacl Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico
[2] Natl Autonomous Univ Mexico, Mexico City 04510, DF, Mexico
关键词
D O I
10.1191/096120301669579565
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:315 / 318
页数:4
相关论文
共 33 条
[1]   Mercury-induced anti-nucleolar autoantibodies can transgress the membrane of living cells in vivo and in vitro [J].
Abedi-Valugerdi, M ;
Hu, H ;
Möller, G .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (04) :605-615
[2]   Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo [J].
Adamus, G ;
Machnicki, M ;
Elerding, H ;
Sugden, B ;
Blocker, YS ;
Fox, DA .
JOURNAL OF AUTOIMMUNITY, 1998, 11 (05) :523-533
[3]   ANTIBODY TO NUCLEAR RIBONUCLEOPROTEIN PENETRATES LIVE HUMAN MONONUCLEAR-CELLS THROUGH FC RECEPTORS [J].
ALARCONSEGOVIA, D ;
RUIZARGUELLES, A ;
FISHBEIN, E .
NATURE, 1978, 271 (5640) :67-69
[4]   The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage [J].
AlarconSegovia, D ;
Llorente, L ;
RuizArguelles, A .
JOURNAL OF AUTOIMMUNITY, 1996, 9 (02) :295-300
[5]  
ALARCONSEGOVIA D, 1979, J IMMUNOL, V122, P1855
[6]  
ALARCONSEGOVIA D, 1983, CLIN EXP IMMUNOL, V52, P365
[7]   ANTIBODY PENETRATION INTO LIVING CELLS .3. EFFECT OF ANTI-RIBONOCLEOPROTEIN IGG ON THE CELL-CYCLE OF HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
ALARCONSEGOVIA, D ;
LLORENTE, L ;
RUIZARGUELLES, A .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1982, 23 (01) :22-33
[8]  
ALARCONSEGOVIA D, 1968, ARTHRITIS RHEUM-US, V11, P462
[9]   ABNORMALITIES IN THE CONTENT OF NUCLEIC-ACIDS OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - RELATIONSHIP TO DNA ANTIBODIES [J].
ALARCONSEGOVIA, D ;
LLORENTE, L ;
FISHBEIN, E ;
DIAZJOUANEN, E .
ARTHRITIS AND RHEUMATISM, 1982, 25 (03) :304-317
[10]  
ALARCONSEGOVIA D, 1979, CLIN EXP IMMUNOL, V35, P364